Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

Following on from the positive opinion given to Xeljanz in January of this year, Pfizer’s drug has now been given European Commission marketing...
Infectex, a Russian portfolio company of Maxwell Biotech Venture Fund, announced that it had found positive results from its latest Phase 2b-3...
AstraZeneca has been boosted by the news that its drug, Tagrisso, has become its first drug to be approved under China’s new Priority Review pathway.
Merck KGaA and Pfizer have won approval for the fourth immunotherapy treatment to enter the market, with an indication in metastatic Merkel cell...

Features

A rundown of five reasons to pay closer attention to the rise of fake medicines across the globe, including some hair-raising statistics on the...

Appointments

DrugDev has announced the appointment of George Masoura who has joined the company as Vice President, Business Development, Europe to support...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches